Different role of tumor necrosis factor-α polymorphism in non-hodgkin lymphomas among caucasian and asian populations: A meta-analysis

International Journal of Molecular Sciences

Volumn 15, Issue 5, 2014, Pages 7684-7698

  Zhai, Kan ^a   Ding, Jie ^a   Zhou, Yan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Case control; Meta analysis; NHL risk; Polymorphism; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B CELL LYMPHOMA; ETHNICITY; FOLLICULAR LYMPHOMA; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; HUMAN; INFLAMMATION; LARGE CELL LYMPHOMA; MANTLE CELL LYMPHOMA; META ANALYSIS; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; T CELL LYMPHOMA; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CAUCASIAN; FACTUAL DATABASE; GENETICS; PATHOLOGY; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; LYMPHOMA, NON-HODGKIN; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899833017     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15057684     Document Type: Article

References (54)

1. Shankland, K.R.; Armitage, J.O.; Hancock, B.W. Non-Hodgkin lymphoma. Lancet 2012, 380, 848-857.
2. Evans, L.S.; Hancock, B.W. Non-Hodgkin lymphoma. Lancet 2003, 362, 139-146.
3. Alexander, D.D.; Mink, P.J.; Adami, H.O.; Chang, E.T.; Cole, P.; Mandel, J.S.; Trichopoulos, D. The non-Hodgkin lymphomas: A review of the epidemiologic literature. Int. J. Cancer 2007, 120 (Suppl. 12), 1-39.
4. Kumar, V.; Matsuo, K.; Takahashi, A.; Hosono, N.; Tsunoda, T.; Kamatani, N.; Kong, S.Y.; Nakagawa, H.; Cui, R.; Tanikawa, C.; et al. Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility. J. Hum. Genet. 2011, 56, 436-439.
5. Skibola, C.F.; Conde, L.; Foo, J.N.; Riby, J.; Humphreys, K.; Sille, F.C.; Darabi, H.; Sanchez, S.; Hjalgrim, H.; Liu, J.; et al. A meta-analysis of genome-wide association studies of follicular lymphoma. BMC Genomics 2012, 13, 516.
6. Zhai, K.; Tian, X.; Wu, C.; Lu, N.; Chang, J.; Huang, L.; Zhang, T.; Zhou, Y.; Qiao, Y.; Yu, D.; et al. Cytokine BAFF gene variation is associated with survival of patients with T-cell lymphomas. Clin. Cancer Res. 2012, 18, 2250-2256.
7. Berndt, S.I.; Skibola, C.F.; Joseph, V.; Camp, N.J.; Nieters, A.; Wang, Z.; Cozen, W.; Monnereau, A.; Wang, S.S.; Kelly, R.S.; et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat. Genet. 2013, 45, 868-876.
8. Tan, D.E.; Foo, J.N.; Bei, J.X.; Chang, J.; Peng, R.; Zheng, X.; Wei, L.; Huang, Y.; Lim, W.Y.; Li, J.; et al. Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat. Genet. 2013, 45, 804-807.
9. Vijai, J.; Kirchhoff, T.; Schrader, K.A.; Brown, J.; Dutra-Clarke, A.V.; Manschreck, C.; Hansen, N.; Rau-Murthy, R.; Sarrel, K.; Przybylo, J.; et al. Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies. PLoS Genet. 2013, 9, e1003220.
10. Zhu, K.; Levine, R.S.; Gu, Y.; Brann, E.A.; Hall, I.; Caplan, L.S.; Baum, M.K. Non-Hodgkin's lymphoma and family history of malignant tumors in a case-control study (United States). Cancer Causes Control 1998, 9, 77-82.
11. Altieri, A.; Bermejo, J.L.; Hemminki, K. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: The Swedish Family-Cancer Database. Blood 2005, 106, 668-672.
12. Wang, S.S.; Slager, S.L.; Brennan, P.; Holly, E.A.; de Sanjose, S.; Bernstein, L.; Boffetta, P.; Cerhan, J.R.; Maynadie, M.; Spinelli, J.J.; et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): A pooled analysis of 10,211 cases and 11,905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007, 109, 3479-3488.
13. Sethi, G.; Sung, B.; Aggarwal, B.B. TNF: A master switch for inflammation to cancer. Front. Biosci. 2008, 13, 5094-5107.
14. Macia, J.; Gomez, X.; Esquerda, A.; Perez, B.; Callao, V.; Marzo, C. Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkins lymphoma. Leuk. Lymphoma 1996, 20, 481-486.
15. Adami, F.; Guarini, A.; Pini, M.; Siviero, F.; Sancetta, R.; Massaia, M.; Trentin, L.; Foa, R.; Semenzato, G. Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemia. Eur. J. Cancer 1994, 30A, 1259-1263.
16. Warzocha, K.; Ribeiro, P.; Bienvenu, J.; Roy, P.; Charlot, C.; Rigal, D.; Coiffier, B.; Salles, G. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998, 91, 3574-3581.
17. Halida, Y.; Guo, X.H.; Aliya, R. Expression of plasma TNF-alpha and TNF-beta in different subtypes lymphoma and its significance. Zhonghua Xue Ye Xue Za Zhi 2011, 32, 695-697. (In Chinese)
18. Wilson, A.G.; di Giovine, F.S.; Duff, G.W. Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J. Inflamm. 1995, 45, 1-12.
19. Neben, K.; Mytilineos, J.; Moehler, T.M.; Preiss, A.; Kraemer, A.; Ho, A.D.; Opelz, G.; Goldschmidt, H. Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood 2002, 100, 2263-2265.
20. Ho, S.Y.; Wang, Y.J.; Chen, H.L.; Chen, C.H.; Chang, C.J.; Wang, P.J.; Chen, H.H.; Guo, H.R. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the-308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 2004, 15, 657-663.
21. Kroeger, K.M.; Carville, K.S.; Abraham, L.J. The-308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 1997, 34, 391-399.
22. Wilson, A.G.; Symons, J.A.; McDowell, T.L.; McDevitt, H.O.; Duff, G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 1997, 94, 3195-3199.
23. Pikarsky, E.; Porat, R.M.; Stein, I.; Abramovitch, R.; Amit, S.; Kasem, S.; Gutkovich-Pyest, E.; Urieli-Shoval, S.; Galun, E.; Ben-Neriah, Y. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431, 461-466.
24. Batten, M.; Fletcher, C.; Ng, L.G.; Groom, J.; Wheway, J.; Laabi, Y.; Xin, X.; Schneider, P.; Tschopp, J.; Mackay, C.R.; et al. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J. Immunol. 2004, 172, 812-822.
25. Skibola, C.F.; Bracci, P.M.; Nieters, A.; Brooks-Wilson, A.; de Sanjose, S.; Hughes, A.M.; Cerhan, J.R.; Skibola, D.R.; Purdue, M.; Kane, E.; et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am. J. Epidemiol. 2010, 171, 267-276.
26. Rothman, N.; Skibola, C.F.; Wang, S.S.; Morgan, G.; Lan, Q.; Smith, M.T.; Spinelli, J.J.; Willett, E.; de Sanjose, S.; Cocco, P.; et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the InterLymph Consortium. Lancet Oncol. 2006, 7, 27-38.
27. Chouchane, L.; Ahmed, S.B.; Baccouche, S.; Remadi, S. Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 1997, 80, 1489-1496.
28. Demeter, J.; Porzsolt, F.; Ramisch, S.; Schmidt, D.; Schmid, M.; Messer, G. Polymorphism of the tumour necrosis factor-α and lymphotoxin-α genes in chronic lymphocytic leukaemia. Br. J. Haematol. 1997, 97, 107-112.
29. Fitzgibbon, J.; Grenzelias, D.; Matthews, J.; Lister, T.A.; Gupta, R.K. Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma. Br. J. Haematol. 1999, 107, 388-391.
30. Wihlborg, C.; Sjoberg, J.; Intaglietta, M.; Axdorph, U.; Pisa, E.K.; Pisa, P. Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia. Br. J. Haematol. 1999, 104, 346-349.
31. Mainou-Fowler, T.; Dickinson, A.M.; Taylor, P.R.; Mounter, P.; Jack, F.; Proctor, S.J.; Nordon, J.; Middleton, P.G. Tumour necrosis factor gene polymorphisms in lymphoproliferative disease. Leuk. Lymphoma 2000, 38, 547-552.
32. Juszczynski, P.; Kalinka, E.; Bienvenu, J.; Woszczek, G.; Borowiec, M.; Robak, T.; Kowalski, M.; Lech-Maranda, E.; Baseggio, L.; Coiffier, B.; et al. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood 2002, 100, 3037-3040.
33. Hellmig, S.; Fischbach, W.; Goebeler-Kolve, M.E.; Folsch, U.R.; Hampe, J.; Schreiber, S. A functional promotor polymorphism of TNF-α is associated with primary gastric B-Cell lymphoma. Am. J. Gastroenterol. 2005, 100, 2644-2649.
34. Bel Hadj Jrad, B.; Chatti, A.; Laatiri, A.; Ahmed, S.B.; Romdhane, A.; Ajimi, S.; Chouchane, L. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. Eur. J. Haematol. 2007, 78, 117-122.
35. Jevtovic-Stoimenov, T.; Kocic, G.; Pavlovic, D.; Macukanovic-Golubovic, L.; Marjanovic, G.; Djordjevic, V.; Tosic, N.; Pavlovic, S. Polymorphisms of tumor-necrosis factor-α-308 and lymphotoxin-α + 250: Possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells. Leuk. Lymphoma 2008, 49, 2163-2169.
36. Fernberg, P.; Chang, E.T.; Duvefelt, K.; Hjalgrim, H.; Eloranta, S.; Sorensen, K.M.; Porwit, A.; Humphreys, K.; Melbye, M.; Ekstrom Smedby, K. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma. Cancer Causes Control 2010, 21, 759-769.
37. Ibrahim, A.; Abdel Rahman, H.; Khorshied, M.; Sami, R.; Nasr, N.; Khorshid, O. Tumor necrosis factor α-308 and Lymphotoxin α + 252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk. Res. 2012, 36, 694-698.
38. Lech-Maranda, E.; Mlynarski, W.; Grzybowska-Izydorczyk, O.; Borowiec, M.; Pastorczak, A.; Cebula-Obrzut, B.; Klimkiewicz-Wojciechowska, G.; Wcislo, M.; Majewski, M.; Kotkowska, A.; et al. Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia. Genes Chromosom. Cancer 2013, 52, 287-296.
39. Xiao, H.; Zhang, K. Genetic polymorphisms of tumor necrosis factor-α and lymphotoxin-α in Chinese patients with non-Hodgkin lymphoma. Ann. Hematol. 2011, 90, 725-727.
40. Hosgood, H.D., 3rd; Au, W.Y.; Kim, H.N.; Liu, J.; Hu, W.; Tse, J.; Song, B.; Wong, K.F.; Lee, J.J.; Chanock, S.J.; et al. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations. Int. J. Hematol. 2013, 97, 793-799.
41. Liu, J.; Song, B.; Wang, T.; Liu, Y.; Hao, J.; Yu, J. Genetic variations in CTLA-4, TNF-α, and LTA and susceptibility to T-cell lymphoma in a Chinese population. Cancer Epidemiol. 2013, 37, 930-934.
42. Nasiri, H.; Farajnia, S.; Rezamand, A.; Movassaghpour, A.A.; Esmaeili, H.A.; Monfaredan, A.; Mobarra, N.; Rahimifar, N.; Sahebi, L.; Farshdousti Hagh, M. Genetic variations of tumor necrosis factor-α-308 and lymphtoxin-α + 252 in non-hodgkin lymphoma and acute lymphoblastic leukemia patients. Iran. J. Basic Med. Sci. 2013, 16, 990-995.
43. Chu, W.M. Tumor necrosis factor. Cancer Lett. 2013, 328, 222-225.
44. Jost, P.J.; Ruland, J. Aberrant NF-κB signaling in lymphoma: Mechanisms, consequences, and therapeutic implications. Blood 2007, 109, 2700-2707.
45. Shih, V.F.; Tsui, R.; Caldwell, A.; Hoffmann, A. A single NF κB system for both canonical and non-canonical signaling. Cell Res. 2011, 21, 86-102.
46. Younes, A.; Aggarwall, B.B. Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders. Cancer 2003, 98, 458-467.
47. Zhang, Q.; Wang, H.Y.; Bhutani, G.; Liu, X.; Paessler, M.; Tobias, J.W.; Baldwin, D.; Swaminathan, K.; Milone, M.C.; Wasik, M.A. Lack of TNFalpha expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK + TCL) cells from apoptosis. Proc. Natl. Acad. Sci. USA 2009, 106, 15843-15848.
48. Brown, T.; Rushton, L. Occupational cancer in Britain. Haematopoietic malignancies: Leukaemia, multiple myeloma, non-Hodgkins lymphoma. Br. J. Cancer 2012, 107 (Suppl. 1), S41-S48.
49. Zhao, X.F.; Reitz, M.; Chen, Q.C.; Stass, S. Pathogenesis of early leukemia and lymphoma. Cancer Biomark. 2010, 9, 341-374.
50. Carroll, M.C.; Katzman, P.; Alicot, E.M.; Koller, B.H.; Geraghty, D.E.; Orr, H.T.; Strominger, J.L.; Spies, T. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc. Natl. Acad. Sci. USA 1987, 84, 8535-8539.
51. Harris, N.L.; Jaffe, E.S.; Diebold, J.; Flandrin, G.; Muller-Hermelink, H.K.; Vardiman, J. Lymphoma classification-from controversy to consensus: The R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann. Oncol. 2000, 11 (Suppl. 1), 3-10.
52. Begg, C.B.; Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50, 1088-1101.
53. Egger, M.; Davey Smith, G.; Schneider, M.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315, 629-634.
54. Lau, J.; Antman, E.M.; Jimenez-Silva, J.; Kupelnick, B.; Mosteller, F.; Chalmers, T.C. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N. Engl. J. Med. 1992, 327, 248-254.